This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Insulin-like growth factor receptor
From Proteopedia
| Line 1: | Line 1: | ||
| - | <StructureSection load=' | + | <StructureSection load='' size='450' side='right' scene='Journal:JBSD:38/Cv/1' caption=''> |
| - | + | ||
| - | + | ||
| - | + | ||
'''Insulin-like growth factor receptors''' (IGFR) are transmembrane receptors which are stimulated by insulin-like growth factors (IGF). IGFR contains 2 extracellular α chains and 2 transmembranal β chains. Upon binding of IGF, a tyrosine in the β chain becomes autophosphorylated and triggers a cascade of intracellular signaling. | '''Insulin-like growth factor receptors''' (IGFR) are transmembrane receptors which are stimulated by insulin-like growth factors (IGF). IGFR contains 2 extracellular α chains and 2 transmembranal β chains. Upon binding of IGF, a tyrosine in the β chain becomes autophosphorylated and triggers a cascade of intracellular signaling. | ||
| + | |||
| + | === Memory-Enhancement by Traditional Chinese Medicine? <ref>doi 10.1080/07391102.2012.741052</ref>=== | ||
| + | Cognitive impairment is an emerging issue and increasing research points to the significant role of insulin-like growth factor I (IGF-I) in cognitive brain functions. <scene name='Journal:JBSD:38/Cv/3'>IGF receptor </scene> (IGF-IR, PDB ID: [[3i81]], <font color='darkmagenta'><b>colored in darkmagenta</b></font>) activation is critical for IGF-I to elicit desirable cognitive functions. Traditional Chinese medicine (TCM) ligands <scene name='Journal:JBSD:38/Cv/2'>3-(2-carboxyphenyl)-4(3H)-quinazolinone</scene> (orgin: ''Isatisin digotica'', <span style="color:lime;background-color:black;font-weight:bold;">colored in green</span>), <scene name='Journal:JBSD:38/Cv/4'>(+)-N-methyllaurotetanine</scene> (origin: ''Lindera aggregate'', <span style="color:deeppink;background-color:black;font-weight:bold;">colored in deeppink</span>), and <scene name='Journal:JBSD:38/Cv/5'>(+)-1(R)-Coclaurine</scene> (origin: ''Nelumbonucifera Gaertn'', <span style="color:salmon;background-color:black;font-weight:bold;">colored in salmon</span>) showed high binding affinity towards IGF-IR at the binding site defined by the control in PDB ID: [[3i81]]. Molecular dynamics simulation revealed that the TCM ligands were secured at the opening of the IGF-IR binding site for the duration of the MD. <scene name='Journal:JBSD:38/Cv/7'>3-(2-carboxyphenyl)-4(3H)-quinazolinone</scene> was stabilized by <scene name='Journal:JBSD:38/Cv/8'>Asp1056</scene>, <scene name='Journal:JBSD:38/Cv/9'>(+)-N-methyllaurotetanine</scene> was stabilized by <scene name='Journal:JBSD:38/Cv/10'>Leu975 and Asp1056</scene>, and <scene name='Journal:JBSD:38/Cv/11'>(+)-1(R)-Coclaurine</scene> was stabilized by <scene name='Journal:JBSD:38/Cv/12'>Leu975 and Gly1055</scene> (<span style="color:yellow;background-color:black;font-weight:bold;">key residues are colored in yellow</span>). Four different quantitative-structure activity relationship models consistently predicted bioactivity of the TCM ligands towards IGF-IR. In summary, the TCM candidates exhibit drug-like potential in both structural-based and ligand-based properties and may have potential for further applications in enhancing cognition. | ||
| + | </StructureSection> | ||
| + | __NOTOC__ | ||
===3D structures of insulin-like growth factor receptor=== | ===3D structures of insulin-like growth factor receptor=== | ||
| Line 32: | Line 34: | ||
[[1syo]], [[1sz0]] - bIGFR II domains 1-3 + mannose-6-phosphate<BR /> | [[1syo]], [[1sz0]] - bIGFR II domains 1-3 + mannose-6-phosphate<BR /> | ||
| + | |||
| + | == References == | ||
| + | |||
| + | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 09:31, 20 November 2013
| |||||||||||
3D structures of insulin-like growth factor receptor
Updated on 20-November-2013
IGFR I
1igr – hIGFR I domains 1-3 – human
1jqh, 1p4o - hIGFR I kinase domain (mutant)
1m7n - hIGFR I kinase domain
1k3a - hIGFR I kinase domain + insulin receptor substrate peptide
2oj9, 2zm3, 3d94, 3f5p, 3i81, 3lvp, 3nw5, 3nw6, 3nw7, 3lw0, 3qqu, 3o23 - hIGFR I kinase domain + inhibitor
IGFR II
1gqb - hIGFR II
2kva - hIGFR II domain 5 – NMR
2cnj - hIGFR II domain 11 - NMR
2l2a - hIGFR II domains 11 (mutant) - NMR
2kvb - hIGFR II domain 5 + inhibitor – NMR
2v5n - hIGFR II domains 11-12
2v5o - hIGFR II domains 11-14
2v5p - hIGFR II domains 11-13 + IGF II
2l29 - hIGFR II domain 11 + IGF II - NMR
1gp0, 1gp3, 1e6f - hIGFR II IGF II-binding domain
1q25 - bIGFR II domains 1-3 – bovine
1syo, 1sz0 - bIGFR II domains 1-3 + mannose-6-phosphate
References
- ↑ Hung IC, Chang SS, Chang PC, Lee CC, Chen CY. Memory enhancement by traditional Chinese medicine? J Biomol Struct Dyn. 2012 Dec 19. PMID:23249175 doi:10.1080/07391102.2012.741052
